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Abstract Several approaches, some of which are described in
this issue, have been proposed to assemble a complete protein
interaction map. These are often based on high throughput
methods that explore the ability of each gene product to bind any
other element of the proteome of the organism. Here we propose
that a large number of interactions can be inferred by revealing
the rules underlying recognition specificity of a small number (a
few hundreds) of families of protein recognition modules. This
can be achieved through the construction and characterization of
domain repertoires. A domain repertoire is assembled in a
combinatorial fashion by allowing each amino acid position in the
binding site of a given protein recognition domain to vary to
include all the residues allowed at that position in the domain
family. The repertoire is then searched by phage display
techniques with any target of interest and from the primary
structure of the binding site of the selected domains one derives
rules that are used to infer the formation of complexes between
natural proteins in the cell. ß 2000 Federation of European
Biochemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Strategies to assemble a protein interaction map
Genomic databases, once translated into protein sequences,
can be viewed as puzzle boxes waiting to be assembled into a
coherent picture that resembles a cell. Given any protein seg-
ment, there are two types of strategies that are helpful in
placing the corresponding protein in the appropriate slot in
the cell puzzle (Fig. 1).
The ¢rst approach is straightforward and comparable to the
strategy utilized by 3-year-old children when they tackle their
¢rst jigsaw puzzle. It consists of a systematic screening of the
limited repertoire of natural peptides in a search for partners
that display a complementary surface. This approach does not
involve any a priori understanding of the rules governing
protein interaction. In principle, this would be the approach
of choice but it is limited by the di⁄culty of obtaining a
complete, equally represented, collection of the proteins in a
cell. It has been suggested that a high throughput implemen-
tation of the yeast two-hybrid method and of MALDI mass
spectrometry could be exploited to develop a complete protein
interaction map of an organism [1^4].
On the other hand, one could take the alternative approach
of deriving a set of rules that eventually would allow one to
infer the binding partners from the primary structure of a
related query protein. This second, perhaps more general,
strategy could be implemented by an experimental approach
that permits exploration of all the sequence space in order to
extract the subset of sequences that have the potential to bind
to the selected bait with an a⁄nity above a certain threshold.
In the hypothesis of a single solution, or a small subset of
related solutions, to the problem of binding a given protein
target, this information can in turn be used to derive the ‘li-
gand signature’ and use it to probe the databases of natural
peptide sequences in search of potential in vivo partners.
It is hoped that by repeating this approach with a manage-
able number of baits one learns general rules that can be
applied to the whole proteome without the need to perform
the selection experiment for each single protein. Although this
approach is less direct, it o¡ers the advantage of searching
synthetic repertoires where all the elements are equally repre-
sented. Furthermore, ligands that bind to the target with af-
¢nity higher than the natural ligand may be selected in the
process thus providing valuable tools to probe the consequen-
ces of disrupting the protein complex in vivo. The limitation
of this approach is that a complete search of the sequence
space of peptides of reasonable size (say a small domain of
50 amino acids) is far beyond the technical limits imposed by
currently available techniques. However, a judicious selection
of the sequence space to be explored (see below) might render
this approach feasible. This review and the accompanying one
[5] will focus on the exploitation of phage display to imple-
ment this second strategy.
2. Searching arti¢cial repertoires
Screening of peptide repertoires has been used by several
groups as a tool to shed light on the mechanisms underlying
speci¢city of ligand recognition in the assembly of macromo-
lecular complexes inside the cell [6^20]. In particular, phage
display libraries of relatively short peptides (6^15 residues) of
random sequence displayed on either pIII or pVIII have been
panned with di¡erent protein recognition domains in order to
deduce the sequence of a consensus ligand. An accompanying
review [5] reports these results in detail and discusses the
implications of the ¢nding that, often, these experiments yield
biologically relevant ligands. That is, the derived consensus
sequences, when used as templates to search a protein data-
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base, often retrieve partners that can be demonstrated to be
physiologically relevant interactors by independent tech-
niques.
3. Protein^protein interaction is often asymmetric
The success of the published experiments that make use of
random peptide repertoires raises the question of whether this
can be considered a general approach to describe protein rec-
ognition speci¢city.
In our group, using a synthetic nonapeptide library dis-
played on the major capsid protein of ¢lamentous phage
[21], we have scored a success rate of approximately 50%.
Approximately half of the protein domains that we have
tested ¢nd, in a random library of 108 linear peptides, a ligand
that binds in the high micromolar a⁄nity range. Since our
library contains peptides with all the possible combinations
of residues in any six out of the nine randomized positions,
fewer than six key residues are su⁄cient to confer to a non-
apeptide the capacity to bind to this class of domains with at
least 100 WM a⁄nity.
Our conclusion is that the molecular surfaces involved in
protein^protein recognition behave di¡erently when tested in
our panning assay. Some succeed in ¢nding short ligands
while others do not. Antibodies, for instance, in the vast ma-
jority of cases ¢nd a partner in these repertoires [22^26]. Fur-
thermore, the deduced consensus sequence is often related to
the sequence in the antigen that was used to raise the anti-
body. This means that, although from the crystallographic
point of view, most epitopes are conformational as they in-
volve interaction with regions of the protein that are far apart
in the primary sequence [27], a large fraction of the binding
energy is contributed by the binding to a relatively short linear
peptide. Whenever the epitope is purely conformational or it
is non-peptidic in nature, the antigen binding site selects a
peptide that mimics the conformational epitope [28,29].
When considering protein^protein interaction in general,
the two models that we have in mind are represented in the
cartoon in Fig. 2. In the ¢rst interaction type the two partners
contribute equally, with a relatively large, more or less £at,
surface. The second type, on the contrary, is asymmetric with
one of the two partners (R, receptor) forming a molecular
pocket that can host a relatively simple structure of the second
partner (L, ligand). Partner R has a more complex involve-
ment since the design of this pocket is likely to require the
structural contribution of relatively distant residues and struc-
tures. In contrast, the participation of partner L is less com-
plex, from a structural point of view, and consists in a rela-
tively short peptide that makes speci¢c contacts in the pocket.
Our panning test allows us to make a clear operational
distinction between the two interaction types, although in na-
ture no clear threshold is likely to exist. In the case of a
symmetric interaction, neither of the two partners will ¢nd
ligands in our peptide collection since both binding surfaces
are extended and cannot be reduced to the simple linear pep-
tides that form our repertoire. By contrast, in an asymmetric
interaction, one of the two partners, the receptor, will be able
to extract a family of ligands from the peptide library while
the other, the ligand, will not.
This discrimination of protein surfaces, operationally de-
¢ned by the ability of the protein to select a clone from a
repertoire of short peptides, depends on the complexity of
the repertoire itself. If we were able to assemble and screen
a repertoire containing all the possible sequences of a peptide
of 100 amino acids, all the proteins would be classi¢ed as
‘receptors’ according to this criterion.
Summarizing, one can exploit short linear peptide reper-
toires displayed by ¢lamentous phage only to investigate pro-
tein recognition mediated by ‘receptor’ proteins, that is by
proteins or domains that have evolved a molecular pocket
that can bind to relatively short linear peptides. This strategy
can help inferring the chemical characteristics of the ligands of
any receptor molecule.
4. Arti¢cial domain repertoires
Since the available techniques do not permit the assembly
of a complete repertoire of peptides of the size of an average
receptor domain, this approach cannot be easily extended to
the identi¢cation of the preferred receptor(s) of any given
natural peptide. Fortunately the problem of complexity is
somewhat reduced by the recognition, supported by numerous
reports in the last decade, that the structure of natural pro-
teins is often modular. Many of these module families are
found repeated several times in the proteome and are often
Fig. 1. The cartoon illustrates two strategies that may be used to as-
semble the protein^protein interaction network in the cell. The
structure indicated with a capital B is the bait.
Fig. 2. Schematic representation of symmetric and asymmetric bind-
ing in protein^protein interaction.
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involved in protein recognition [30,31]. This is simpli¢ed by
the structure of the Src kinase where one can identify three
domains (SH1, SH2, SH3) that are found repeatedly in a
number of other proteins [32,33]. Although new modules,
proposed to be involved in protein interaction, are continu-
ously reported in the literature, it is clear that their total
number does not exceed a few hundred. In any case they
are far from including all the sequence and/or structure space.
At the moment the SMART database includes approximately
400 entries and a sizeable fraction of these motifs are involved
in protein recognition [34]. Thus, the fraction of peptides in
the sequence space that have had any chance of experiencing
natural selection is small and those that have been selected
tend to cluster in a small number of de¢ned regions of the
sequence/structure space.
These considerations lead us to a second approach, com-
plementary to the one that aims at building arti¢cial peptide
repertoires as large and as complete as possible. Instead of
using a very general, but inevitably incomplete repertoire, we
aim at mirroring the natural proteome which, for the scope of
modulating protein interaction, has selected a limited number
of di¡erent sca¡olds, each specialized in recognizing speci¢c
molecular characteristics of the protein surfaces. For instance
the SH3 (or WW) sca¡old to bind poly-proline peptides, the
SH2 (or PTB) sca¡old for phospho-tyrosine peptides and the
PDZ sca¡old for carboxy-terminal peptides.
One could think of assembling a limited number of di¡erent
domain libraries by randomizing the ligand binding surface of
one representative domain for each of the natural families.
Since, in this case, the ligand sequence space that we are
aiming for is much more restricted, the problem becomes
accessible. Furthermore we can learn from the molecular scaf-
folds that have been selected during evolution and we are
likely to have a better chance of success in assembling a col-
lection of repertoires that is complete, and contains receptors
for any given physiologically signi¢cant peptide ligand.
The question ‘which peptides in the sequence space bind to
the query peptide’ can then be rephrased into two simpler
questions: (i) ‘which subset of peptide sequence space repre-
sented in the proteome (domain repertoire) contains a ligand
for a query peptide?’ and (ii) ‘which element of this restricted
repertoire has the potential to bind to the query peptide?’ The
answer, obtained by panning the di¡erent domain repertoires,
could provide hints about the possible natural ligands and
help in the development of speci¢c protein interaction inhib-
itors, ‘perturbagens’, to be used to interfere with cell pathways
[35^40].
5. A general repertoire to bind poly-proline peptides
To illustrate the approach in more detail, we will describe
the strategy that we have utilized to design a collection of
molecules that bind to poly-proline containing peptides (Fig.
3, Panni et al., in preparation). The selected sca¡old consists
of the four L-strand sandwich that characterizes the SH3 do-
main family [41]. An alternative sca¡old evolved to bind pro-
line-rich peptides is the WW domain sca¡old [7,42].
SH3 domains bind to their targets by accommodating the
ligand in a binding surface formed by three molecular pockets
[43^45]. Two of them are hydrophobic and host the PXXP
motif which is considered the mark of SH3 ligands. The third
pocket is normally negatively charged and determines the spe-
ci¢city and the orientation of the ligand by hosting a posi-
tively charged residue that either precedes or follows the
PXXP core motif. Peptides characterized by the RXXPXXP
motif bind in an orientation called ‘class I’ orientation, while
peptides displaying the PXXPXR motif accommodate the car-
boxy-terminal R in the hydrophilic pocket and bind in the
opposite orientation (class II) [45].
More than 1000 SH3 domains can be identi¢ed in protein
sequence databases [34] and those that have already been
characterized are known to bind to poly-proline stretches con-
tained in a variety of proteins involved in signal transduction,
cytoskeleton organization and membrane tra⁄c [46]. Poly-
proline sequences are relatively common in the proteome.
For instance, yeast proteins containing a PXXP core motif,
which identi¢es potential targets for SH3 domains, are 3300
out of a total 6148 predicted open reading frames [47]. We
decided to design a molecular repertoire that would contain
elements that could bind to any of these potential targets with
su⁄cient a⁄nity and speci¢city.
In order to assemble an SH3 domain repertoire, we selected
a structurally well characterized SH3 domain sca¡old, the one
belonging to the protein Abl [43], and identi¢ed all the resi-
dues that form the binding surface and are in contact with a
peptide ligand. By varying the residue composition of the
binding surface in a combinatorial fashion, one should obtain
a collection of SH3 molecules with a wide speci¢city spectrum.
However, because of the large number of possible combina-
tions, such a repertoire would be largely incomplete and
would probably include many elements that do not fold prop-
erly. Thus, we restricted the variation of the chemical charac-
teristic of the binding surface to the residues that are found at
the corresponding positions in natural SH3 domains.
Two hundred and ninety SH3 domains in the SMART
Fig. 3. Strategy to design, assemble and exploit a domain repertoire.
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database were aligned and the frequencies of all the residues
at each of the 13 sites that make contact with the target pep-
tide were determined. Some of these positions are very con-
served. At position 110 the vast majority of SH3s have Trp
while in the RT loop (S75^T79) almost all residues are repre-
sented in natural SH3s. Then we designed a degenerate gene
sequence that encodes hybrid SH3s displaying, on the Abl
sca¡old, a collection of binding surfaces that include most
of those that are found in natural SH3 domains.
The selection of residues that are allowed at each position is
somewhat limited and biased by the characteristics of the
genetic code. However, a judicious choice of the degeneracy
of the nucleotide sequence makes it possible to assemble a
repertoire that contains most of the residues present in natural
SH3 in the peptide binding surface.
The residues that are allowed, at each position, by the se-
quence of the degenerate gene that we have designed are re-
ported in Fig. 4. The total number of possible SH3 domains in
this combinatorial repertoire is 1.5U109, while the actual size
of the library that we have constructed is 108.
The ¢rst question that we wanted to address is whether this
collection of arti¢cial SH3 domains contain elements that can
bind to most of the peptides folding in poly-proline helix II
conformation. To answer this question the SH3 repertoire,
displayed by fusion to the carboxy-terminus of the V D pro-
tein [48,49], was panned with several peptides that were used
as baits.
These experiments, whose results are summarized in Fig. 5,
and similar results obtained with di¡erent peptide baits, indi-
cate that most, possibly all, poly-proline peptides that fold in
a helix II conformation have a ligand partner in our SH3
domain library. Furthermore, SH3 domains that have a
high degree of speci¢city can be selected by this approach.
We have also shown that, by using as baits folded proteins
exposing poly-proline peptides (for instance the HIV protein
Nef), one can select partners that have high a⁄nity and spe-
ci¢city (Panni et al., in preparation). By this approach one can
identify the residues that are involved in binding speci¢city
and extract recognition rules that help in associating any
poly-proline peptide to a set of speci¢c residues in the SH3
binding surface. The assumption is that the speci¢c sca¡old
that is selected, in this case the Abl-SH3 domain, plays a
minor role in ligand recognition and that residues that are
buried in the domain structure, or far away from the ligand,
can be, in a ¢rst approximation, neglected.
The above mentioned experiments were done by panning in
vitro an SH3 repertoire displayed by fusion to the COOH-
terminus of the D protein of bacteriophage V. The same rep-
ertoire, however, can be expressed in vivo, in practically any
organism, by inserting the degenerate gene sequence into a
suitable expression vector. Thus, by exploiting appropriate
selection systems, the repertoire can be used to isolate ele-
ments that inhibit biological pathways by interacting with
proteins that display a poly-proline helix on their surface
[35^40].
Similar experiments were carried out by Schneider and col-
laborators [50] who utilized the two-hybrid selection system to
extract arti¢cial PDZ domains recognizing di¡erent carboxy-
terminal peptides from a PDZ degenerate library. Further-
more the same authors demonstrated that such arti¢cial
PDZ domains can be used to target intracellular proteins to
di¡erent subcellular compartments. Another domain, whose
binding speci¢city can be changed by minor alterations of
the ligand binding residues, is the WW domain [51].
Fig. 4. SH3 repertoire. The three-dimensional structure of the SH3 domain of the Abl kinase is represented as a ribbon. The sca¡old is shaded
in dark while the residues that have been shown to make contact with the target peptides are in a lighter shade. These include 13 residues:
Y70, F72, S75, G76, D77, N78, T79, N94, E98, W99, W110, N114, Y115. The letters in the gray boxes represent all the amino acids that are
encoded by a gene of degenerate sequence in the corresponding positions.
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Thus we conclude that general repertoires of protein bind-
ing domains can be assembled by randomizing speci¢c posi-
tions of the domain ligand binding surface. These repertoires
can be searched, for instance by phage display techniques,
with any bait of interest and from the chemical characteristics
of the selected domains one can learn rules underlying protein
recognition speci¢city and utilize these rules to predict ligands
of newly discovered natural domains.
6. Perspectives
The last decade has witnessed a £ourishing of new tools to
study protein^protein interaction [52,53]. The speed with
which binding information is acquired by these methods is
such that, whatever the scienti¢c interest, most groups have
adopted and are using them to obtain hints about the protein
interaction web in the speci¢c physiological niche of their
interest. The impact of these tools in molecular biology re-
search is such that one can hardly come across grant or fel-
lowship applications where these methods are not mentioned
as important tools in the proposal. Some recent reports or
unpublished work, which we have described here, suggest
that the construction and panning of arti¢cial domain reper-
toires can help decipher the rules underlying protein recogni-
tion speci¢city mediated by small structurally conserved pro-
tein modules. These rules in turn can be used to identify
putative targets of newly discovered elements of these domain
families. Sometimes these rules are simple and can be easily
incorporated in a pattern search algorithm. For instance in
the case of the WW domain a single residue in the target
recognition surface was shown to mediate ligand speci¢city
[51] (Kasanov and Kay, personal communication). By con-
trast, extensive work on the SH3 domain has not revealed a
small number of residues that make it possible to infer ligand
preference in a straightforward manner. Also in this case,
however, the data collected from panning both peptide or
domain repertoires can be organized in a domain-speci¢c res-
idue to residue contact matrix to be used with a score function
to evaluate the likelihood that a given domain would bind to
any speci¢c poly-proline peptide [54].
The general consensus is that eventually only ‘traditional’,
and time consuming, genetic experiments will provide the def-
inite proof that the interactions, discovered by these arti¢cial
tools, have any functional relevance in vivo. However, the
large number of reports that describe the successful exploita-
tion of display methods in the discovery of new interaction
partners has established them as unavoidable approaches to
restrict the number of putative ligands. One must realize,
however, that the intrinsic limit of these methods is that
they only provide information about the a⁄nity of the two
putative partners under investigation. A⁄nity is only one of
the factors that determine whether a speci¢c complex is
formed in vivo. Local protein concentration mediated by co-
valent linkage to localization signals or other protein interac-
tion domains often plays a more important role than absolute
a⁄nity. Nevertheless, a ‘complete’, biochemically naive, inter-
action map, where each link established between two proteins
by any of the methods described in this issue is associated
Fig. 5. Sequence characteristics of SH3 domains that bind to Src-type or Abl-type peptides. We have characterized approximately 20 domains
that bind to a peptide that displays a consensus similar to peptides recognized by the Abl SH3 domain (left) or by the Src SH3 domain (right).
The font size in the gray boxes are proportional to the frequency of occurrence of the speci¢c residue at that variable position of the repertoire
in the selected domains. The residues that, although present in the repertoire, were never found in the selected domains are in black boxes. The
¢rst peptide (Abl) is homologous to many peptides recognized by the Abl wild type SH3 while the second (Src) is a preferred target for SH3
domains of Src-type kinase. Both peptides, after a couple of panning cycles, could select ligands from the SH3 domain repertoire. The two sets
of SH3 domains, however, were distinct and SH3 domains that recognize the Abl peptide would not bind to the Src peptide and vice versa. By
comparing the sequence in the degenerate regions of the SH3 binding to the Abl or to the Src peptide, it was possible to identify regularities.
For instance, all the SH3 domains that bind to the Abl peptide had a Trp at position 110 while most hydrophobic residues were tolerated at
this position by Src peptide ligands. By contrast a Cys was strongly preferred at position 94 in Src peptide ligands.
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with a ‘reliability coe⁄cient’, would be very much welcomed
by the community of biologists and by commercial companies
looking for new drug targets. Some recently developed com-
putational tools for genome-wide prediction of protein inter-
action maps could also contribute to the assessment of such
coe⁄cients [55^58].
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